Qiang Ren

机构：China Pharmaceutical University, Drug Discovery Laboratory (Norway) · ORCID：0000-0002-4728-8676

发表论文 88 篇 · 总被引 1444 次 · h-index 20

代表论文

• A redox-active perylene-anthraquinone donor-acceptor conjugated microporous polymer with an unusual electron delocalization channel for photocatalytic reduction of uranium (VI) in strongly acidic solution (2022 · Applied Catalysis B: Environmental · 被引 157)
• Novel Co3O4@TiO2@CdS@Au double-shelled nanocage for high-efficient photocatalysis removal of U(VI): Roles of spatial charges separation and photothermal effect (2023 · Journal of Hazardous Materials · 被引 73)
• Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease (2023 · Journal of Medicinal Chemistry · 被引 25)
• Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease (2025 · Journal of Medicinal Chemistry · 被引 16)
• Recent advances in the treatment of gout with NLRP3 inflammasome inhibitors (2024 · Bioorganic & Medicinal Chemistry · 被引 16)
• A chondroitin sulfate purified from shark cartilage and bovine serum albumin interaction activity (2024 · International Journal of Biological Macromolecules · 被引 12)